ILMN vs. CRL

In the year-to-date period, ILMN achieves a -42.12% return, which is significantly lower than CRL's -37.89% return. Over the past 10 years, ILMN has underperformed CRL with an annualized return of -8.08%, while CRL has yielded a comparatively higher 5.20% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Illumina, Inc. (ILMN) and Charles River Laboratories International, Inc. (CRL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ILMN Sharpe Ratio is -0.86, which is comparable to the CRL Sharpe Ratio of -1.04. The chart below compares the historical Sharpe Ratios of ILMN and CRL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ILMN nor CRL has paid dividends to shareholders.

The maximum ILMN drawdown since its inception was -96.14%, which is greater than CRL's maximum drawdown of -78.23%. Use the drawdown chart below to compare losses from any high point for ILMN and CRL. For additional features, visit the drawdowns tool.

The current volatility for Illumina, Inc. (ILMN) is 17.00%, while Charles River Laboratories International, Inc. (CRL) has a volatility of 38.85%. This indicates that ILMN experiences smaller price fluctuations and is considered to be less risky than CRL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Illumina, Inc. and Charles River Laboratories International, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.